Key result
Implantation of the Freestyle stentless bioprosthesis for extensive aortic valve endocarditis resulted in 83% and 70% overall survival at 1 and 5 years, respectively, with 11% early mortality.
Why the study?
What are the clinical and echocardiographic outcomes of using the Freestyle stentless bioprosthesis in patients with extensive aortic valve endocarditis?
Population
54 patients with extensive aortic valve endocarditis involving the root, mean age 61 ± 13 years, 74% male…
Design
Cohort
Follow-up
median 3.5 years (range 0 to 15 years)
Authors
Loading...
Supports Freestyle for LVOT reconstruction after endocarditis debridement; leaves open comparative durability versus homografts pending randomized data.
Observational (n=54)
What are the clinical and echocardiographic outcomes of using the Freestyle stentless bioprosthesis in patients with extensive aortic valve endocarditis?
The Freestyle stentless bioprosthesis provides a versatile and durable solution for reconstructing the left ventricular outflow tract in extensive aortic valve endocarditis, demonstrating good late survival and low recurrence rates.
Schneider et al. (2016) conducted an observational in Extensive aortic valve endocarditis (n=54). Freestyle stentless bioprosthesis was evaluated on Clinical and echocardiographic outcome (including mortality and survival). Implantation of the Freestyle stentless bioprosthesis for extensive aortic valve endocarditis resulted in 83% and 70% overall survival at 1 and 5 years, respectively, with 11% early mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: